Concepedia

Lubna Therachiyil

LT

Statistics

Publications

8

Citations

264

H-Index

8

Active since

2017

Affiliations

Hamad Medical Corporation(Current)

Qatar University

Weill Cornell Medical College in Qatar

Cornell University

Weill Cornell Medicine

Lubna Therachiyil is an author at Hamad Medical Corporation specializing in oncology, molecular oncology, and apoptosis.

Publications per year

2017–2024

8

Publications

8

Anticancer Activity of Camel Milk via Induction of Autophagic Death in Human Colorectal and Breast Cancer Cells

Roopesh Krishnankutty, Ahmad Iskandarani, Lubna Therachiyil et al. · Asian Pacific Journal of Cancer Prevention · 2018 · 66 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Role of RAS signaling in ovarian cancer

Lubna Therachiyil, Anjana Anand, Abdullah Azmi et al. · F1000Research · 2022 · 42 citations · Full text

Medicine, Gynecology, Oncology +17

Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells

Kirti S. Prabhu, Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan et al. · PLoS ONE · 2017 · 39 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways

Lubna Therachiyil, Roopesh Krishnankutty, Fareed Ahmad et al. · International Journal of Molecular Sciences · 2022 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin

Lubna Therachiyil, Javeria Haroon, Fairooz Sahir et al. · Frontiers in Oncology · 2020 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 8